Is obesity-induced ECM remodeling a prelude to the development of various diseases?

被引:2
|
作者
Rahimi, Azam [1 ]
Rasouli, Mehdi [1 ]
Keshel, Saeed Heidari [1 ]
Ebrahimi, Maryam [2 ]
Pakdel, Farzad [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn & Appl Cell Sci, Tehran, Iran
[2] Farabi Eye Hosp, Dept Ophthalm Plast & Reconstruct Surg, Tehran, Iran
[3] Univ Tehran Med Sci, Eye Res Ctr, Ophthalmol Dept, Tehran, Iran
关键词
Extracellular matrix; Remodeling; Insulin resistance; Obesity; Organ crosstalk; Organ dysfunction; HIGH-FAT DIET; ADIPOSE-TISSUE; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; EXPRESSION; ACTIVATION; INCREASES; LOCALIZATION; INFLAMMATION; ANGIOGENESIS;
D O I
10.1016/j.orcp.2023.02.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to the increasing incidence rate of obesity worldwide and the associated complications such as type 2 diabetes and cardiovascular diseases, research on the adipose tissue physiology and the role of the extracellular matrix (ECM) has gained tremendous attention. The ECM, one of the most crucial components in body tissues, undergoes remodeling and regeneration of its constituents to guarantee normal tissue function. There is a crosstalk between fat tissue and various body organs, including but not limited to the liver, heart, kidney, skeletal muscle, and so forth. These organs respond to fat tissue signals through changes in ECM, function, and their secretory products. Obesity can cause ECM remodeling, inflammation, fibrosis, insulin resistance, and disrupted metabolism in different organs. However, the mechanisms underlying the reciprocal communication between various organs during obesity are still not fully elucidated. Gaining a profound knowledge of ECM alterations during the progression of obesity will pave the way toward developing potential strategies to either circumvent pathological conditions or open an avenue to treat complications associated with obesity.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [41] METHOTREXATE: AN OPTION FOR OBESITY-INDUCED ASTHMA?
    Knight, Seth
    Khosravi, Mehdi
    CHEST, 2021, 160 (04) : 1765A - 1765A
  • [42] OBESITY-INDUCED HYPERPLASTIC LUNG GROWTH
    INSELMAN, LS
    WAPNIR, RA
    SPENCER, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 135 (03): : 613 - 616
  • [43] RENAL PATHOPHYSIOLOGY IN OBESITY-INDUCED HYPERTENSION
    HALL, JE
    HERRERA, GA
    GRANGER, JP
    HYPERTENSION, 1991, 18 (03) : 395 - 395
  • [44] Fanning the flames of obesity-induced inflammation
    Shoelson, Steven E.
    Goldfine, Allison B.
    NATURE MEDICINE, 2009, 15 (04) : 373 - 374
  • [45] Leptin as a Mediator of Obesity-Induced Hypertension
    Bell, Balyssa B.
    Rahmouni, Kamal
    CURRENT OBESITY REPORTS, 2016, 5 (04): : 397 - 404
  • [46] Diagnosis and Management of Obesity-Induced Lymphedema
    Greene, Arin K.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 138 (01) : 111E - 118E
  • [47] Obesity-induced hypermethylation of adiponectin gene
    Claire Greenhill
    Nature Reviews Endocrinology, 2015, 11 (9) : 504 - 504
  • [48] Unraveling the mechanisms of obesity-induced hyperoxaluria
    Sakhaee, Khashayar
    KIDNEY INTERNATIONAL, 2018, 93 (05) : 1038 - 1040
  • [49] Obesity-induced liver inflammation (NASH)
    Cassard-Doulcier, Anne-Marie
    Perlemuter, Gabriel
    CAHIERS DE NUTRITION ET DE DIETETIQUE, 2011, 46 (05): : 240 - 246
  • [50] Overcoming obesity-induced immunotherapeutic failure
    Boi, Shannon Kathryn
    Orlandella, Rachael
    Gibson, Justin Tyler
    Starenki, Dmytro
    Makkouk, Amani
    Joshi, Vijaya
    Gross, Brett
    Salem, Aliasger
    Weiner, George
    Norian, Lyse A.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):